how mutation screening impacts transplant decisions in mds
Published 2 years ago • 74 plays • Length 3:10Download video MP4
Download video MP3
Similar videos
-
2:44
the impact of mutation screening on transplant decisions in mds
-
2:48
how can mutational screening guide current clinical practice in mds?
-
3:56
the genetic landscape of mds and impact on treatment
-
3:36
the genetic landscape of mds: how this is improving & impacting the development of therapies
-
3:22
transplantation in mf: patient-centered communication and decision making
-
7:46
outcomes in patients with ms who receive immune checkpoint inhibitors as cancer treatment
-
1:13
how to thaw profile® step-by-step guide with richard reish, md
-
7:54
patient/caregiver stories - living with mds
-
5:43
pre- and post-allohsct treatment in mds
-
2:35
methods of optimizing transplantation in mds
-
3:16
developing patient-specific mrd markers for predicting and preventing mds relapse post-sct
-
2:18
prognostic factors and mutations in mds
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
3:58
prognosis & advances in treatment strategies for sf3b1-mutant mds
-
4:31
labmt: impact of treatment prior to allogenic hct in mds
-
2:16
current and future treatment approaches for hr-mds
-
2:38
impact: expediting transplantation trials
-
1:03
the importance of the mdt in managing transplant survivors
-
3:19
key clinical trials in mds taking place in the us
-
1:44
utilizing chromosome banding in mds
-
2:09
heart transplantation in attr amyloidosis
-
1:05
optimizing the treatment of transplant-eligible ndmm: using quadruplets in induction & consolidation